相似文献
1
Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.
Emerg Infect Dis. 2022 Dec;28(13):S238-S243. doi: 10.3201/eid2813.212477.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
Emerg Infect Dis. 2022 Aug;28(8):1734-1736. doi: 10.3201/eid2808.220650. Epub 2022 Jun 22.
4
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.
5
COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.
BMJ Open. 2022 Mar 23;12(3):e057741. doi: 10.1136/bmjopen-2021-057741.
6
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Vaccine. 2022 Jan 24;40(3):512-520. doi: 10.1016/j.vaccine.2021.11.092. Epub 2021 Dec 10.
7
Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).
J Res Health Sci. 2022 Jun 30;22(2):e00551. doi: 10.34172/jrhs.2022.86.
8
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
PLoS Med. 2021 Nov 5;18(11):e1003823. doi: 10.1371/journal.pmed.1003823. eCollection 2021 Nov.
9
Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
Emerg Infect Dis. 2022 Oct;28(10):2126-2130. doi: 10.3201/eid2810.221134. Epub 2022 Aug 29.
10
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
Clin Microbiol Infect. 2022 Apr;28(4):596-601. doi: 10.1016/j.cmi.2021.11.023. Epub 2021 Dec 13.
引用本文的文献
1
Comparative efficacy of leading COVID-19 vaccines: A network meta-analysis.
Indian J Med Res. 2025 Jan;161(1):9-20. doi: 10.25259/IJMR_750_2024.
2
COVID-19: vaccination, therapeutics and a review of the science and public health.
Ann Med Surg (Lond). 2024 Jul 17;86(9):5343-5353. doi: 10.1097/MS9.0000000000002374. eCollection 2024 Sep.
3
Ethnic inequalities in coverage and use of women's cancer screening in Peru.
BMC Womens Health. 2024 Jul 24;24(1):418. doi: 10.1186/s12905-024-03225-6.
4
Healthcare personnel in 2016-2019 prospective cohort infrequently got vaccinated, worked while ill, and frequently used antibiotics rather than antivirals against viral influenza illnesses.
Influenza Other Respir Viruses. 2023 Sep 7;17(9):e13189. doi: 10.1111/irv.13189. eCollection 2023 Sep.
5
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.
BMC Med. 2023 Apr 27;21(1):160. doi: 10.1186/s12916-023-02861-3.
6
Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
Emerg Infect Dis. 2022 Dec;28(13):S26-S33. doi: 10.3201/eid2813.212248.
7
Global Responses to the COVID-19 Pandemic.
Emerg Infect Dis. 2022 Dec;28(13):S4-S7. doi: 10.3201/eid2813.221733.
本文引用的文献
1
COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.
Nat Med. 2021 Jul;27(7):1230-1238. doi: 10.1038/s41591-021-01378-7. Epub 2021 May 25.
2
Access to and equitable distribution of COVID-19 vaccine in low-income countries.
NPJ Vaccines. 2021 Apr 14;6(1):54. doi: 10.1038/s41541-021-00323-6.
3
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
4
Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2021726118.
5
Impact of COVID-19 lockdown policy on homicide, suicide, and motor vehicle deaths in Peru.
Prev Med. 2021 Feb;143:106331. doi: 10.1016/j.ypmed.2020.106331. Epub 2020 Nov 21.
6
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.
Lancet Public Health. 2020 Sep;5(9):e475-e483. doi: 10.1016/S2468-2667(20)30164-X. Epub 2020 Jul 31.
7
Risk of death by age and gender from CoVID-19 in Peru, March-May, 2020.
Aging (Albany NY). 2020 Jul 21;12(14):13869-13881. doi: 10.18632/aging.103687.
8
The Peru Approach against the COVID-19 Infodemic: Insights and Strategies.
Am J Trop Med Hyg. 2020 Aug;103(2):583-586. doi: 10.4269/ajtmh.20-0536. Epub 2020 Jun 4.
9
COVID-19 strains remote regions of Peru.
Lancet. 2020 May 30;395(10238):1684. doi: 10.1016/S0140-6736(20)31236-8.
10
Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016-2018.
Influenza Other Respir Viruses. 2020 Jul;14(4):391-402. doi: 10.1111/irv.12737. Epub 2020 Apr 5.
Zotero 插件